A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Revenue Growth Up 44%; Net Loss Improved by Almost $700,000 Company to Begin Shipments of Evolve Soft Bait Next Week Expected to Be a Key Driver of Revenue Growth PHOENIX, Nov. 9, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"),...
Financial results to be released after market close;Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 2, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2023, ended September 30, 2023, after the market close on...
The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX, Nov. 1, 2023 -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage...
SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. We are experts in fertility control to manage animal pest populations. We invented ContraPest, the only U.S. EPA-registered...
The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX, Oct. 17, 2023 -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and...
PHOENIX, Oct. 9, 2023 -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will present and host one-on-one meetings with investors at the Lytham Partners Fall 2023 Investor...
PHOENIX, Sept. 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that...
Isolate Bait System™ Now Shipping PHOENIX, Aug. 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats,...
July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Aug. 10, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 3, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on...